Abstract:BACKGROUND:Prostate cancer (PCa) is the second leading cause of tumor-related mortality in men. Metastasis from advanced tumors is the primary cause of death among patients. Identifying novel and effective biomarkers is essential for understanding the mechanisms of metastasis in PCa patients and developing successful interventions. METHODS:Using the GSE8511 and GSE27616 data sets, 21 metastasis-related genes were identified through the weighted gene co-expression network analysis (WGCNA) method. Subsequent functional analysis of these genes was conducted on the gene set cancer analysis (GSCA) website. Cluster analysis was utilized to explore the relationship between these genes, immune infiltration in PCa, and the efficacy of targeted drug IC50 scores. Machine learning algorithms were then employed to construct diagnostic and prognostic models, assessing their predictive accuracy. Additionally, multivariate COX regression analysis highlighted the significant role of POLD1 and examined its association with DNA methylation. Finally, molecular docking and immunohistochemistry experiments were carried out to assess the binding affinity of POLD1 to PCa drugs and its impact on PCa prognosis. RESULTS:The study identified 21 metastasis-related genes using the WGCNA method, which were found to be associated with DNA damage, hormone AR activation, and inhibition of the RTK pathway. Cluster analysis confirmed a significant correlation between these genes and PCa metastasis, particularly in the context of immunotherapy and targeted therapy drugs. A diagnostic model combining multiple machine learning algorithms showed strong predictive capabilities for PCa diagnosis, while a transfer model using the LASSO algorithm also yielded promising results. POLD1 emerged as a key prognostic gene among the metastatic genes, showing associations with DNA methylation. Molecular docking experiments supported its high affinity with PCa-targeted drugs. Immunohistochemistry experiments further validated that increased POLD1 expression is linked to poor prognosis in PCa patients. CONCLUSIONS:The developed diagnostic and metastasis models provide substantial value for patients with prostate cancer. The discovery of POLD1 as a novel biomarker related to prostate cancer metastasis offers a promising avenue for enhancing treatment of prostate cancer metastasis.

A Machine Learning Method for Predicting Biomarkers Associated with Prostate Cancer

Integrated machine learning algorithms reveal a bone metastasis-related signature of circulating tumor cells in prostate cancer

Machine learning-based cell death marker for predicting prognosis and identifying tumor immune microenvironment in prostate cancer

Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion

Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing

Identification of Metastasis-Related Genes for Predicting Prostate Cancer Diagnosis, Metastasis and Immunotherapy Drug Candidates Using Machine Learning Approaches

Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining

Identification and validation of diagnostic and prognostic biomarkers in prostate cancer based on WGCNA

Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.

An Integrative Proteomics And Interaction Network-Based Classifier For Prostate Cancer Diagnosis

Novel Gene Signatures for Prostate Cancer Detection: Network Centrality-based Screening with Experimental Validation

Identification of Candidate Hub Genes Correlated with the Pathogenesis, Diagnosis, and Prognosis of Prostate Cancer by Integrated Bioinformatics Analysis.

Machine Learning-Based Models Enhance the Prediction of Prostate Cancer

Identification of novel biomarkers in prostate cancer diagnosis and prognosis

Machine learning-driven mast cell gene signatures for prognostic and therapeutic prediction in prostate cancer

Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 As Potential Key Genes Associated with Prostate Cancer.

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.

Four Novel Prognostic Genes Related to Prostate Cancer Identified Using Co-expression Structure Network Analysis

Identification of blood protein biomarkers associated with prostate cancer risk using genetic prediction models: analysis of over 140 000 subjects

Comprehensive Analysis of Biomarkers for Prostate Cancer Based on Weighted Gene Co-Expression Network Analysis

Machine-learning Algorithm-based Risk Prediction and Screening-detected Prostate Cancer in A Benign Prostate Hyperplasia Cohort